Title Image
You are in:  / Home  /  investigation   /  Treatment of age-related macular degeneration of the neovascular type (DMAEh) over 2 years with a treatment and extension model (T + E) of 2 mg aflibercept injected into the eye.
ACTUALIDAD

 

RESEARCHER:

Dr. Álvaro Fernández-Vega Sanz

 ACTIVO 

 

Treatment of age-related macular degeneration of the neovascular type (DMAEh) over 2 years with a treatment and extension model (T + E) of 2 mg aflibercept injected into the eye.


INDICATION: Patients with Macular Degeneration Associated with the Wet Age
TREATMENT: Aflibercept
PROMOTOR: Bayer AG